Allogene Therapeutics, Inc. (ALLO) Social Stream
ALLOGENE THERAPEUTICS INC (ALLO) Price Targets From Analysts
Use the tables below to see what analysts covering ALLOGENE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-15 | 14 | $45 | $18 | $33.833 | $3.21 | 953.99% |
| 2021-12-22 | 14 | $43 | $18 | $32.583 | $3.21 | 915.05% |
| 2022-01-11 | 14 | $43 | $14 | $32.666 | $3.21 | 917.63% |
| 2022-02-04 | 14 | $43 | $14 | $31.75 | $3.21 | 889.1% |
| 2022-02-24 | 13 | $43 | $14 | $30.666 | $3.21 | 855.33% |
| 2022-03-04 | 13 | $43 | $14 | $29.916 | $3.21 | 831.96% |
| 2022-03-09 | 13 | $43 | $14 | $29.75 | $3.21 | 826.79% |
| 2022-03-22 | 14 | $43 | $14 | $29 | $3.21 | 803.43% |
| 2022-05-05 | 14 | $43 | $13 | $26.75 | $3.21 | 733.33% |
| 2022-05-16 | 15 | $43 | $13 | $26 | $3.21 | 709.97% |
| 2022-05-24 | 16 | $43 | $9 | $24.692 | $3.21 | 669.22% |
| 2022-06-03 | 16 | $43 | $9 | $23.714 | $3.21 | 638.75% |
| 2022-07-15 | 16 | $43 | $11 | $25.769 | $3.21 | 702.77% |
| 2022-08-02 | 16 | $43 | $11 | $25.357 | $3.21 | 689.94% |
| 2022-08-09 | 16 | $43 | $11 | $25.357 | $3.21 | 689.94% |
| 2022-08-18 | 16 | $43 | $11 | $25.769 | $3.21 | 702.77% |
| 2022-09-17 | 16 | $43 | $11 | $25.615 | $3.21 | 697.98% |
| 2022-10-07 | 16 | $43 | $11 | $25.384 | $3.21 | 690.78% |
| 2022-10-09 | 14 | $43 | $11 | $25.153 | $3.21 | 683.58% |
| 2022-11-03 | 15 | $43 | $11 | $24.461 | $3.21 | 662.02% |
| 2022-11-30 | 15 | $32 | $11 | $23.384 | $3.21 | 628.47% |
| 2022-12-12 | 15 | $32 | $9 | $22.23 | $3.21 | 592.52% |
| 2022-12-20 | 15 | $32 | $9 | $21.846 | $3.21 | 580.56% |
| 2023-01-05 | 16 | $32 | $6 | $21.142 | $3.21 | 558.63% |
| 2023-01-06 | 15 | $32 | $6 | $21.153 | $3.21 | 558.97% |
| 2023-03-01 | 15 | $32 | $6 | $20.461 | $3.21 | 537.41% |
| 2023-03-02 | 16 | $35 | $6 | $19 | $3.21 | 491.9% |
| 2023-03-21 | 17 | $35 | $6 | $18.133 | $3.21 | 464.89% |
| 2023-04-04 | 17 | $35 | $6 | $17.733 | $3.21 | 452.43% |
| 2023-04-20 | 17 | $35 | $6 | $17.733 | $3.21 | 452.43% |
| 2023-05-05 | 17 | $35 | $6 | $17.7 | $3.21 | 451.4% |
| 2023-06-06 | 17 | $35 | $6 | $16.966 | $3.21 | 428.54% |
| 2023-06-26 | 18 | $35 | $6 | $16.966 | $3.21 | 428.54% |
| 2023-07-12 | 18 | $35 | $6 | $16.833 | $3.21 | 424.39% |
| 2023-08-07 | 17 | $35 | $5 | $16.6 | $3.21 | 417.13% |
| 2023-09-25 | 17 | $35 | $5 | $16.533 | $3.21 | 415.05% |
| 2023-09-28 | 17 | $35 | $3 | $16.333 | $3.21 | 408.82% |
| 2023-11-03 | 17 | $35 | $3 | $15.966 | $3.21 | 397.38% |
| 2023-11-06 | 17 | $35 | $3 | $15.033 | $3.21 | 368.32% |
| 2023-11-15 | 17 | $35 | $3 | $14.3 | $3.21 | 345.48% |
| 2023-12-15 | 17 | $35 | $3 | $13.633 | $3.21 | 324.7% |
The Trend in the Analyst Price Target
Over the past 51 weeks, ALLO's average price target has gone down $8.21.
ALLO reports an average of 269.83% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-06 | 16 | 32 | 6 | 21.214 | 6.09 | 248.34% |
| 2023-05-05 | 17 | 35 | 6 | 16.966 | 6.60 | 157.06% |
| 2023-09-25 | 17 | 35 | 5 | 16.533 | 3.51 | 371.03% |
| 2023-11-15 | 18 | 35 | 3 | 14.300 | 2.72 | 425.74% |
| 2023-12-08 | 17 | 35 | 3 | 13.633 | 2.47 | 451.94% |
ALLO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.47 | 13 | 1 | 2 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
ALLO's average broker recommendation rating improved by 0.12 over the prior 35 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ALLO has a greater upside potential (average analyst target price relative to current price) than 5223.28% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, ALLOGENE THERAPEUTICS INC's variance in analysts' estimates is lower than -5021.78% of them.
- ALLO has a greater number of analysts covering the stock than 5219.76% of stocks in the mid market cap category.
- ALLO has a higher average analyst price target than 1763.9% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, KRYS, MESO, and IOVA are the three stocks most similar to ALLOGENE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ALLO using the data that counts. Try POWR Ratings for free.